Clinical Trial Update: Improving Health Outcomes With Kefir [NA]

View source ↗

Summary

A clinical trial is recruiting to study the effects of kefir on inflammatory response, type 2 diabetes, and cardiovascular outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Systemic Inflammatory Response Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Kefir

Snippet

Sponsor: University of Alberta | Conditions: Systemic Inflammatory Response, Diabetes Mellitus, Type 2 | NA | Status: RECRUITING